A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor.
Saved in:
| Title: | A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor. |
|---|---|
| Authors: | Maher TM; Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Simpson JK; GlaxoSmithKline Research and Development, Stevenage, UK., Porter JC; University College London Hospital, London, UK., Wilson FJ; GlaxoSmithKline Research and Development, Stevenage, UK., Chan R; GlaxoSmithKline Research and Development, Stevenage, UK., Eames R; GlaxoSmithKline Research and Development, Stevenage, UK., Cui Y; GlaxoSmithKline Research and Development, Stevenage, UK., Siederer S; GlaxoSmithKline Research and Development, Stevenage, UK., Parry S; GlaxoSmithKline Research and Development, Stevenage, UK., Kenny J; GlaxoSmithKline Research and Development, Stevenage, UK., Slack RJ; GlaxoSmithKline Research and Development, Stevenage, UK., Sahota J; University College London Hospital, London, UK., Paul L; Royal Brompton Hospital, London, UK., Saunders P; Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Molyneaux PL; Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Lukey PT; GlaxoSmithKline Research and Development, Stevenage, UK., Rizzo G; Invicro, A Konica Minolta Company, London, UK., Searle GE; Invicro, A Konica Minolta Company, London, UK., Marshall RP; GlaxoSmithKline Research and Development, Stevenage, UK., Saleem A; Invicro, A Konica Minolta Company, London, UK., Kang'ombe AR; GlaxoSmithKline Research and Development, Stevenage, UK., Fairman D; GlaxoSmithKline Research and Development, Stevenage, UK., Fahy WA; GlaxoSmithKline Research and Development, Stevenage, UK., Vahdati-Bolouri M; GlaxoSmithKline Research and Development, Stevenage, UK. mitra.x.vahdati-bolouri@gsk.com. |
| Source: | Respiratory research [Respir Res] 2020 Mar 26; Vol. 21 (1), pp. 75. Date of Electronic Publication: 2020 Mar 26. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32216814 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Maher+TM%22">Maher TM</searchLink>; Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Simpson+JK%22">Simpson JK</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Porter+JC%22">Porter JC</searchLink>; University College London Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Wilson+FJ%22">Wilson FJ</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Chan+R%22">Chan R</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Eames+R%22">Eames R</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Cui+Y%22">Cui Y</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Siederer+S%22">Siederer S</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Parry+S%22">Parry S</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Kenny+J%22">Kenny J</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Slack+RJ%22">Slack RJ</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Sahota+J%22">Sahota J</searchLink>; University College London Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Paul+L%22">Paul L</searchLink>; Royal Brompton Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Saunders+P%22">Saunders P</searchLink>; Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Molyneaux+PL%22">Molyneaux PL</searchLink>; Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lukey+PT%22">Lukey PT</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Rizzo+G%22">Rizzo G</searchLink>; Invicro, A Konica Minolta Company, London, UK.<br /><searchLink fieldCode="AU" term="%22Searle+GE%22">Searle GE</searchLink>; Invicro, A Konica Minolta Company, London, UK.<br /><searchLink fieldCode="AU" term="%22Marshall+RP%22">Marshall RP</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Saleem+A%22">Saleem A</searchLink>; Invicro, A Konica Minolta Company, London, UK.<br /><searchLink fieldCode="AU" term="%22Kang'ombe+AR%22">Kang'ombe AR</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Fairman+D%22">Fairman D</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Fahy+WA%22">Fahy WA</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Vahdati-Bolouri+M%22">Vahdati-Bolouri M</searchLink>; GlaxoSmithKline Research and Development, Stevenage, UK. mitra.x.vahdati-bolouri@gsk.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101090633%22">Respiratory research</searchLink> [Respir Res] 2020 Mar 26; Vol. 21 (1), pp. 75. <i>Date of Electronic Publication: </i>2020 Mar 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101090633 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-993X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214659921%22">14659921 </searchLink><i>NLM ISO Abbreviation: </i>Respir Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32216814 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12931-020-01339-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 75 Titles: – TitleFull: A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Maher TM – PersonEntity: Name: NameFull: Simpson JK – PersonEntity: Name: NameFull: Porter JC – PersonEntity: Name: NameFull: Wilson FJ – PersonEntity: Name: NameFull: Chan R – PersonEntity: Name: NameFull: Eames R – PersonEntity: Name: NameFull: Cui Y – PersonEntity: Name: NameFull: Siederer S – PersonEntity: Name: NameFull: Parry S – PersonEntity: Name: NameFull: Kenny J – PersonEntity: Name: NameFull: Slack RJ – PersonEntity: Name: NameFull: Sahota J – PersonEntity: Name: NameFull: Paul L – PersonEntity: Name: NameFull: Saunders P – PersonEntity: Name: NameFull: Molyneaux PL – PersonEntity: Name: NameFull: Lukey PT – PersonEntity: Name: NameFull: Rizzo G – PersonEntity: Name: NameFull: Searle GE – PersonEntity: Name: NameFull: Marshall RP – PersonEntity: Name: NameFull: Saleem A – PersonEntity: Name: NameFull: Kang'ombe AR – PersonEntity: Name: NameFull: Fairman D – PersonEntity: Name: NameFull: Fahy WA – PersonEntity: Name: NameFull: Vahdati-Bolouri M IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 03 Text: 2020 Mar 26 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1465-993X Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: Respiratory research Type: main |
| ResultId | 1 |